To inform clinical management strategies and optimize guidelines for cancer risk management in female and male BRCA1/2 carriers, we comprehensively assess the associations of BRCA1/2 PVs with risks of 22 cancers, other than female breast and ovarian cancers. The gene discussed is BRCA1; the disease is ovarian carcinoma.